Imaging modalities for measuring body composition in patients with cancer: opportunities and challenges

• Published in: Journal of the National Cancer Institute. Monographs Vol. 2023; no. 61; pp. 56 - 67
• Main Authors: Shah, Urvi A, Ballinger, Tarah J, Bhandari, Rusha, Dieli-Cornwright, Christina M, Guertin, Kristin A, Hibler, Elizabeth A, Kalam, Faiza, Lohmann, Ana Elisa, Ippolito, Joseph E
• Format: Journal Article
• Language: English
• Published: United States 04.05.2023
• Subjects: Absorptiometry, Photon; Body Composition; Body Mass Index; Electric Impedance; Humans; Magnetic Resonance Imaging; Neoplasms - diagnostic imaging; Positron-Emission Tomography; Skinfold Thickness; Tomography Scanners, X-Ray Computed
• ISSN: 1052-6773; 1745-6614
• DOI: 10.1093/jncimonographs/lgad001

Body composition assessment (ie, the measurement of muscle and adiposity) impacts several cancer-related outcomes including treatment-related toxicities, treatment responses, complications, and prognosis. Traditional modalities for body composition measurement include body mass index, body circumference, skinfold thickness, and bioelectrical impedance analysis; advanced imaging modalities include dual energy x-ray absorptiometry, computerized tomography, magnetic resonance imaging, and positron emission tomography. Each modality has its advantages and disadvantages, thus requiring an individualized approach in identifying the most appropriate measure for specific clinical or research situations. Advancements in imaging approaches have led to an abundance of available data, however, the lack of standardized thresholds for classification of abnormal muscle mass or adiposity has been a barrier to adopting these measurements widely in research and clinical care. In this review, we discuss the different modalities in detail and provide guidance on their unique opportunities and challenges.